
    
      This trial is to assess the perioperative complications, hospitalization expenses and days,
      and one year disease-free survival of patients who underwent total or subtotal colectomy as
      part of the surgical procedures for ovarian cancer, versus partial intestinal resection in
      the therapy for ovarian cancer.
    
  